Navigation Links
Free 2D/3D Advanced Visualization Software for CT and MRI Now Available From FiatLux Imaging
Date:11/3/2009

REDMOND, Wash., Nov. 3 /PRNewswire/ -- Medical software company FiatLux Imaging, Inc., located in Redmond, WA, announces the availability of FiatLux Visualize(TM) Free, advanced 2D/3D visualization software for CT and MRI imaging data. The free software is available for any healthcare professional via download from www.FiatLuxImaging.com. There is no charge for download or use.

"There is tremendous unrealized potential in medical imaging data," stated Quentin Dewolf, CEO of FiatLux Imaging.

"CT and MRI scanners generate huge amounts of data every day, yet the vast majority of that data is never seen outside of the radiology suite. If it were, we believe referring physicians could make better decisions, patients could gain insight into their conditions, and the expense and inconvenience of duplicate scans could be avoided.

We deliver advanced visualization to any healthcare professional, not just the small number of radiologists using expensive software on high-end workstations."

FiatLux Visualize Free is the only free advanced visualization software for CT and MRI imaging data that runs on virtually any modern Windows PC/laptop/notebook/tablet - including Windows 7 - and is cleared by the FDA for clinical use in the United States. FiatLux Visualize Free is a fully-featured 2D/3D visualization application - not a demo - for any healthcare professional needing an easy-to-use means of reformatting and viewing DICOM-compatible imaging data.

The software is useful for any healthcare professional, including specialists such as surgeons and cardiologists, primary care physicians, radiologists and radiologic technologists, physician's assistants, and clinical nurse specialists. Medical students and residents will find FiatLux Visualize Free invaluable for studying anatomy, identifying pathology, and reviewing cases.

Typical uses of FiatLux Visualize Free include an easy-to-use, 2D/3D viewer of images on CD or DVD, radiologist report verification, patient education, and procedure planning.

According to Dewolf, "We are offering this software for free because we believe that democratizing medical imaging data is important in the context of healthcare reform and because it is the fastest way to build a user community. We plan to add valuable features based on the input of those users. Many features will remain free and some will be available for a fee, referred to as the 'freemium' approach."

FiatLux Imaging, founded in 2007, is dedicated to transforming medical imaging data into insight...for anyone. www.FiatLuxImaging.com

    Contact:
    Tom Sanko
    FiatLux Imaging, Inc.
    Tom.Sanko@FiatLuxImaging.com
    425.605.0902
    www.FiatLuxImaging.com

SOURCE FiatLux Imaging, Inc.


'/>"/>
SOURCE FiatLux Imaging, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 2016 According to responses from U.S. oncologists that ... of patients with non-small cell lung cancer (NSCLC), treatment decisions ... genetic mutation status. The findings of the survey were presented ... #P3.02b ) at the 2016 World Conference on Lung ... The survey results revealed an overall high rate of ...
(Date:12/7/2016)... Dec. 7, 2016 Boehringer Ingelheim today ... patients with unresectable malignant pleural mesothelioma (MPM) met ... data, presented at the 17 th IASLC ... Vienna , showed nintedanib plus pemetrexed/cisplatin demonstrated ... pemetrexed/cisplatin, with a significantly improved PFS (9.4 vs ...
(Date:12/7/2016)... YORK , December 7, 2016 ... Pharmaceuticals PLC (NASDAQ: JAZZ ), Anthera Pharmaceuticals Inc. ... DNAI ), and AveXis Inc. (NASDAQ: AVXS ... Sector Index fell roughly 37% to reach a level equal ... it is down by approximately 14% for the year, it ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... , ... AlignLife clinics nationwide are giving back to their communities by collecting ... bountiful gifts wrapped tightly under a Christmas Tree. AlignLife hopes to spread the ... , In exchange for generous donations, customers will receive a gift in return. ...
(Date:12/7/2016)... ... December 07, 2016 , ... Sharon Kleyne, host of the ... and Your Health on Voice of America, declared on her radio program in November ... the fact that when these bullies attack leaders in corporate America, they are trying ...
(Date:12/7/2016)... ... , ... Delete® - Tattoo Removal and Laser Salon Offers Delightful Holiday Deals ... To 33% Off Botox® and Juvederm® Products Now Through December 31, 2016 , Delete® ... Deals on Botox® and Juvederm® just in time for the holiday party season. ...
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... its newest portable bioelectronic medicine device WellnessPro Plus for consumers and healthcare ... enhances the WellnessPro platform by expanding the treatment modalities available in a ...
Breaking Medicine News(10 mins):